Breakdown | ||||
Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
---|---|---|---|---|
Income Statement | Total Revenue | |||
12.73M | 15.94M | 32.66M | 49.75M | 44.35M | Gross Profit |
8.14M | 9.56M | 13.69M | 16.39M | 12.71M | EBIT |
626.59K | 4.55M | 6.34M | 8.77M | 1.78M | EBITDA |
2.89M | 6.13M | 8.46M | 11.61M | 5.09M | Net Income Common Stockholders |
2.00M | 4.82M | 6.16M | 8.45M | 1.02M |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | |||
18.57M | 21.19M | 11.06M | 9.21M | 4.59M | Total Assets |
23.03M | 27.64M | 29.45M | 33.92M | 32.64M | Total Debt |
725.40K | 1.42M | 1.47M | 3.94M | 11.89M | Net Debt |
-17.84M | -19.77M | -9.53M | -5.27M | 7.30M | Total Liabilities |
3.82M | 5.82M | 6.90M | 12.89M | 19.70M | Stockholders Equity |
19.21M | 21.82M | 22.55M | 21.03M | 12.95M |
Cash Flow | Free Cash Flow | |||
2.06M | 4.76M | 8.57M | 16.44M | 6.71M | Operating Cash Flow |
2.06M | 4.77M | 8.60M | 16.47M | 6.82M | Investing Cash Flow |
677.27K | 898.61K | 445.79K | 41.78K | 71.25K | Financing Cash Flow |
-5.37M | 4.51M | -7.23M | -11.90M | -6.87M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
74 Outperform | HK$22.44M | 1.92 | 42.01% | ― | 4.39% | ― | |
60 Neutral | $10.96B | 10.27 | -6.73% | 2.97% | 7.73% | -11.60% | |
58 Neutral | HK$24.06M | 12.38 | 11.00% | 7.69% | -15.78% | -46.15% | |
40 Underperform | HK$60.80M | ― | ― | -15.26% | 27.67% | ||
39 Underperform | HK$166.82M | ― | -82.56% | ― | 79.84% | -219.70% | |
34 Underperform | HK$73.14M | ― | ― | 98.29% | 65.99% |